Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mental health status of transmasculine adults before and after gender affirming hormonal therapy
TCTR20250123005Completed
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of testosterone in gender dysphoria (GD), sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoint: Change in mental health status. Started Sep 2023; status: completed.
02
Drugs
testosterone
03
Conditions
gender dysphoria (GD)
Beyond the preview
Go deeper on TCTR20250123005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250123005.